ABCG2 and chronic myelogenous leukemia, BCR-ABL1 positive: In addition, since imatinib is a substrate of ABC transporters, some scientists believe in the role of these transporters and their regulatory factors (non-coding RNAs), in development of chemoresistance in CML cells [94,103,104].